Literature DB >> 11015480

Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children.

S M Arpadi1, P A Cuff, D P Kotler, J Wang, M Bamji, M Lange, R N Pierson, D E Matthews.   

Abstract

The study objectives were to assess the relationships among human immunodeficiency virus (HIV) replication, energy balance, body composition and growth in children with HIV-associated growth failure (GF). Energy intake and expenditure, body composition and level of HIV RNA were measured in 16 HIV-infected children with growth failure (HIV+/GF+), defined as a 12-mo height velocity </= 5th percentile for age, and 26 HIV-infected children with normal rates of growth (HIV+/GF-). Energy intake was measured by repeated 24-h dietary recall, resting energy expenditure (REE) by indirect calorimetry and total energy expenditure (TEE) by the doubly labeled water method. Fat-free mass (FFM) was determined by dual X-ray energy absorptiometry and plasma HIV RNA by the polymerase chain reaction method. The mean plasma HIV RNA content among the HIV+/GF+ group was nearly 1.5 log higher than that of the HIV+/GF- group (4. 89 +/- 1.08 vs. 3.43 +/- 1.64 x10(2) copies/L, P: = 0.009). The mean daily energy intake, and age-adjusted REE and TEE were lower in HIV+/GF+ children (P: = 0.003, 0.06 and 0.16, respectively). HIV+/GF+ children had a mean daily energy deficit of 674 +/- 732 kJ/d compared with HIV+/GF- children who had a mean energy surplus of 1448 +/- 515 kJ/d (P: = 0.030). There were no differences in REE after adjustment for differences in FFM and age using multiple regression analysis (P: = 0.88). There was a significant inverse relationship between FFM and plasma HIV RNA [R:(2) = 0.64, standard error of the estimate (SEE) = 3.23] and between viral load and 12-mo growth velocity (R:(2) = 0.61, SE = 1.51). Viral load and energy intake were also inversely related (R(2) = 0.17, SEE = 573.2, P: = 0. 0125). In HIV-infected children, rate of growth, quantity of FFM and energy intake are closely related to the level of HIV replication. The energy intake of children with HIV-associated GF may not be adequate for supporting normal development of FFM and growth, despite possible decreases in total energy expenditure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015480     DOI: 10.1093/jn/130.10.2498

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  15 in total

1.  Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.

Authors:  C J Chantry; J S Cervia; M D Hughes; C Alvero; J Hodge; P Borum; J Moye
Journal:  HIV Med       Date:  2010-03-21       Impact factor: 3.180

2.  Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy.

Authors:  Jing Shen; Afaaf Liberty; Stephanie Shiau; Renate Strehlau; Sheila Pierson; Faeezah Patel; LiQun Wang; Megan Burke; Avy Violari; Ashraf Coovadia; Elaine J Abrams; Stephen Arpadi; Marc Foca; Louise Kuhn
Journal:  AIDS Res Hum Retroviruses       Date:  2019-07-15       Impact factor: 2.205

3.  Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study.

Authors:  T L Miller; K A Easley; W Zhang; E J Orav; D M Bier; E Luder; A Ting; W T Shearer; J H Vargas; S E Lipshultz
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

4.  Duration of hospitalization and appetite of HIV-infected South African children.

Authors:  Siyazi Mda; Joop M A van Raaij; Una E MacIntyre; François P R de Villiers; Frans J Kok
Journal:  Matern Child Nutr       Date:  2011-04       Impact factor: 3.092

5.  Growth patterns and anaemia status of HIV-infected children living in an institutional facility in India.

Authors:  Prasanna K Kapavarapu; Omar Bari; Mathew Perumpil; Christopher Duggan; Chitra Dinakar; Shubha Krishnamurthy; Karthika Arumugam; Anita Shet
Journal:  Trop Med Int Health       Date:  2012-06-12       Impact factor: 2.622

6.  Clinical predictors of HIV infection in hospitalized children aged 2-18 months in Harare, Zimbabwe.

Authors:  K J Nathoo; S Rusakaniko; O Tobaiwa; H A Mujuru; I Ticklay; L Zijenah
Journal:  Afr Health Sci       Date:  2012-09       Impact factor: 0.927

Review 7.  Patterns of postnatal growth in HIV-infected and HIV-exposed children.

Authors:  Sheila Isanaka; Christopher Duggan; Wafaie W Fawzi
Journal:  Nutr Rev       Date:  2009-06       Impact factor: 7.110

8.  Growth, immune and viral responses in HIV infected African children receiving highly active antiretroviral therapy: a prospective cohort study.

Authors:  Philippa M Musoke; Peter Mudiope; Linda N Barlow-Mosha; Patrick Ajuna; Danstan Bagenda; Michael M Mubiru; Thorkild Tylleskar; Mary G Fowler
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

9.  Variability of growth in children starting antiretroviral treatment in southern Africa.

Authors:  Thomas Gsponer; Ralf Weigel; Mary-Ann Davies; Carolyn Bolton; Harry Moultrie; Paula Vaz; Helena Rabie; Karl Technau; James Ndirangu; Brian Eley; Daniela Garone; Maureen Wellington; Janet Giddy; Jochen Ehmer; Matthias Egger; Olivia Keiser
Journal:  Pediatrics       Date:  2012-09-17       Impact factor: 7.124

10.  Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin).

Authors:  Dana S Hardin
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.